Results 151 to 160 of about 23,419,181 (286)

The Use of Multiple Imputation for Data Subject to Limits of Detection. [PDF]

Sri Lankan J Appl Stat, 2014
Harel O, Perkins N, Schisterman EF.
europepmc   +1 more source

Higher Education Competency Dataset based on the TEC21 Educational Model of Tecnologico de Monterrey

The dataset includes anonymized information related to undergraduate students who have taken at least one semester in the TEC21 Educational Model at Tecnologico de Monterrey in Mexico from August-December 2019 to February-June 2022 (six cohorts).
IFE Data Hub
core   +1 more source

Differential expression of cancer‐related genes supports prediction of poor response to first‐line treatments in T‐ALL pediatric patients with high minimal residual disease

Molecular Oncology, EarlyView.
In the present work, we have identified a transcriptional signature based on the differential expression of six genes (BCL2&MAST4, HSH2D&LAT2, METRN&PITPNM2) that would facilitate the early detection of T‐cell acute lymphoblastic leukemia (T‐ALL) patients prone to a poor treatment response and could be implemented at diagnosis, along with other risk ...
Antonio Lahera, Laura Vela‐Martín, Pablo Fernández‐Navarro, José Luis López‐Lorenzo, Javier Cornago, Pilar Llamas, Eduardo Pérez‐Gómez, José Luis Marín‐Rubio, Manuel Fresno, Javier Santos, José Fernández‐Piqueras, María Villa‐Morales   +11 more
wiley   +1 more source

Functional Requirements for Subject Authority Data (FRSAD) - A Conceptual Model

, 2011
The purpose of authority control is to ensure consistency in representing a value - a name of a person, a place name, or a term or code representing a subject - in the elements used as access points in information retrieval.
IFLA Working Group on the Functional Requirements for Subject Authority Records (FRSAR)
core   +1 more source

Analysis of colorectal adenoma recurrence data subject to informative censoring. [PDF]

Cancer Epidemiol Biomarkers Prev, 2009
Hsu CH, Taylor JM, Long Q, Alberts DS.
europepmc   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

Molecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan, Veronika M Metzler, Simone de Brot, Corinne L Woodcock, Anna E Harris, Jennifer Lothion‐Roy, Emeli M Nilsson, Atara Ntekim, Michael S Toss, Jenny L Persson, Francesca Khani, Brian D Robinson, Lorraine J Gudas, Emad Rakha, David M Heery, Catrin S Rutland, Nigel P Mongan   +16 more
wiley   +1 more source

Data with subject

, 2021
openaire   +1 more source

Jointly modeling the relationship between longitudinal and survival data subject to left truncation with applications to cystic fibrosis. [PDF]

Stat Med, 2012
Piccorelli AV, Schluchter MD.
europepmc   +1 more source

Transcriptional profiling of circulating extracellular vesicles from prebiopsy prostate cancer patients

Molecular Oncology, EarlyView.
RNA profiling of circulating extracellular vesicles (EVs) from blood samples of men undergoing prostate biopsy identifies transcripts associated with clinically significant prostate cancer. Integrative analysis with public tumor datasets links EV‐derived gene signatures to tumor stage and progression‐free survival, highlighting CASP3, XRCC2, and RIT1 ...
Stefan Werner, Pierre Tennstedt, Randi C. Pose, Christian Müller, Katharina Besler, Svenja Schneegans, Malik Alawi, Marie C. Roesch, Sven Peine, Desiree Bonci, Joanna Budna‐Tukan, Evi Lianidou, Catherine Alix‐Panabières, Derya Tilki, Klaus Pantel   +14 more
wiley   +1 more source

Implementing informed consent in federated medical research: a blueprint designed to safeguard data subject rights in Germany. [PDF]

J Transl Med
Hampf C, Pley AW, Penndorf P, Moser FM, Lang S, Werner P, Kästner A, Leddig T, Stahl D, Hoffmann W, Bialke M.   +10 more
europepmc   +1 more source